Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Asset Utilization Ratio: 2024-2025

Historic Asset Utilization Ratio for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to 0.05.

  • Tonix Pharmaceuticals Holding's Asset Utilization Ratio fell 65.72% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year decrease of 65.72%. This contributed to the annual value of 0.06 for FY2024, which is N/A change from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Asset Utilization Ratio of 0.05 as of Q3 2025, which was down 9.43% from 0.05 recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Asset Utilization Ratio peaked at 0.14 during Q3 2024, and registered a low of 0.05 during Q3 2025.
  • Moreover, its 2-year median value for Asset Utilization Ratio was 0.07 (2024), whereas its average is 0.08.
  • Data for Tonix Pharmaceuticals Holding's Asset Utilization Ratio shows a maximum YoY tumbled of 65.72% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Tonix Pharmaceuticals Holding's Asset Utilization Ratio stood at 0.08 in 2024, then plummeted by 65.72% to 0.05 in 2025.
  • Its Asset Utilization Ratio was 0.05 in Q3 2025, compared to 0.05 in Q2 2025 and 0.06 in Q1 2025.